Cargando…

Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro

BACKGROUND: Characterization of combination effects of chemotherapy drugs with carbon ions in comparison to photons in vitro. METHODS: The human colon adenocarcinoma cell line WiDr was tested for combinations with camptothecin, cisplatin, gemcitabine and paclitaxel. In addition three other human tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlaich, Fabian, Brons, Stephan, Haberer, Thomas, Debus, Jürgen, Combs, Stephanie E, Weber, Klaus-Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827887/
https://www.ncbi.nlm.nih.gov/pubmed/24192264
http://dx.doi.org/10.1186/1748-717X-8-260
_version_ 1782291161579257856
author Schlaich, Fabian
Brons, Stephan
Haberer, Thomas
Debus, Jürgen
Combs, Stephanie E
Weber, Klaus-Josef
author_facet Schlaich, Fabian
Brons, Stephan
Haberer, Thomas
Debus, Jürgen
Combs, Stephanie E
Weber, Klaus-Josef
author_sort Schlaich, Fabian
collection PubMed
description BACKGROUND: Characterization of combination effects of chemotherapy drugs with carbon ions in comparison to photons in vitro. METHODS: The human colon adenocarcinoma cell line WiDr was tested for combinations with camptothecin, cisplatin, gemcitabine and paclitaxel. In addition three other human tumour cell lines (A549: lung, LN-229: glioblastoma, PANC-1: pancreas) were tested for the combination with camptothecin. Cells were irradiated with photon doses of 2, 4, 6 and 8 Gy or carbon ion doses of 0.5, 1, 2 and 3 Gy. Cell survival was assessed using the clonogenic growth assay. Treatment dependent changes in cell cycle distribution (up to 12 hours post-treatment) were measured by FACS analysis after propidium-iodide staining. Apoptosis was monitored for up to 36 hours post-treatment by Nicoletti-assay (with qualitative verification using DAPI staining). RESULTS: All cell lines exhibited the well-known increase of killing efficacy per unit dose of carbon ion exposure, with relative biological efficiencies at 10% survival (RBE(10)) ranging from 2.3 to 3.7 for the different cell lines. In combination with chemotherapy additive toxicity was the prevailing effect. Only in combination with gemcitabine or cisplatin (WiDr) or camptothecin (all cell lines) the photon sensitivity was slightly enhanced, whereas purely independent toxicities were found with the carbon ion irradiation, in all cases. Radiation-induced cell cycle changes displayed the generally observed dose-dependent G2-arrest with little effect on S-phase fraction for all cell lines for photons and for carbon ions. Only paclitaxel showed a significant induction of apoptosis in WiDr cell line but independent of the used radiation quality. CONCLUSIONS: Combined effects of different chemotherapeutics with photons or with carbon ions do neither display qualitative nor substantial quantitative differences. Small radiosensitizing effects, when observed with photons are decreased with carbon ions. The data support the idea that a radiochemotherapy with common drugs and carbon ion irradiation might be as feasible as respective photon-based protocols. The present data serve as an important radiobiological basis for further combination experiments, as well as clinical studies on combination treatments.
format Online
Article
Text
id pubmed-3827887
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38278872013-11-15 Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro Schlaich, Fabian Brons, Stephan Haberer, Thomas Debus, Jürgen Combs, Stephanie E Weber, Klaus-Josef Radiat Oncol Research BACKGROUND: Characterization of combination effects of chemotherapy drugs with carbon ions in comparison to photons in vitro. METHODS: The human colon adenocarcinoma cell line WiDr was tested for combinations with camptothecin, cisplatin, gemcitabine and paclitaxel. In addition three other human tumour cell lines (A549: lung, LN-229: glioblastoma, PANC-1: pancreas) were tested for the combination with camptothecin. Cells were irradiated with photon doses of 2, 4, 6 and 8 Gy or carbon ion doses of 0.5, 1, 2 and 3 Gy. Cell survival was assessed using the clonogenic growth assay. Treatment dependent changes in cell cycle distribution (up to 12 hours post-treatment) were measured by FACS analysis after propidium-iodide staining. Apoptosis was monitored for up to 36 hours post-treatment by Nicoletti-assay (with qualitative verification using DAPI staining). RESULTS: All cell lines exhibited the well-known increase of killing efficacy per unit dose of carbon ion exposure, with relative biological efficiencies at 10% survival (RBE(10)) ranging from 2.3 to 3.7 for the different cell lines. In combination with chemotherapy additive toxicity was the prevailing effect. Only in combination with gemcitabine or cisplatin (WiDr) or camptothecin (all cell lines) the photon sensitivity was slightly enhanced, whereas purely independent toxicities were found with the carbon ion irradiation, in all cases. Radiation-induced cell cycle changes displayed the generally observed dose-dependent G2-arrest with little effect on S-phase fraction for all cell lines for photons and for carbon ions. Only paclitaxel showed a significant induction of apoptosis in WiDr cell line but independent of the used radiation quality. CONCLUSIONS: Combined effects of different chemotherapeutics with photons or with carbon ions do neither display qualitative nor substantial quantitative differences. Small radiosensitizing effects, when observed with photons are decreased with carbon ions. The data support the idea that a radiochemotherapy with common drugs and carbon ion irradiation might be as feasible as respective photon-based protocols. The present data serve as an important radiobiological basis for further combination experiments, as well as clinical studies on combination treatments. BioMed Central 2013-11-06 /pmc/articles/PMC3827887/ /pubmed/24192264 http://dx.doi.org/10.1186/1748-717X-8-260 Text en Copyright © 2013 Schlaich et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Schlaich, Fabian
Brons, Stephan
Haberer, Thomas
Debus, Jürgen
Combs, Stephanie E
Weber, Klaus-Josef
Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
title Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
title_full Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
title_fullStr Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
title_full_unstemmed Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
title_short Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
title_sort comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827887/
https://www.ncbi.nlm.nih.gov/pubmed/24192264
http://dx.doi.org/10.1186/1748-717X-8-260
work_keys_str_mv AT schlaichfabian comparisonoftheeffectsofphotonversuscarbonionirradiationwhencombinedwithchemotherapyinvitro
AT bronsstephan comparisonoftheeffectsofphotonversuscarbonionirradiationwhencombinedwithchemotherapyinvitro
AT habererthomas comparisonoftheeffectsofphotonversuscarbonionirradiationwhencombinedwithchemotherapyinvitro
AT debusjurgen comparisonoftheeffectsofphotonversuscarbonionirradiationwhencombinedwithchemotherapyinvitro
AT combsstephaniee comparisonoftheeffectsofphotonversuscarbonionirradiationwhencombinedwithchemotherapyinvitro
AT weberklausjosef comparisonoftheeffectsofphotonversuscarbonionirradiationwhencombinedwithchemotherapyinvitro